CSLLY
CSL is a global biotechnology company composed of CSL Behring, CSL Seqirus, and CSL Vifor, delivering lifesaving medicines and vaccines across more than 100 countries. The company focuses on rare and serious diseases, plasma-derived and recombinant therapies, influenza vaccines, and therapies for iron deficiency and nephrology, with R&D and manufacturing capabilities spanning multiple continents. Since 1916, CSL has combined commercial strength with research-driven innovation to improve patient outcomes worldwide. Its three business units concentrate on plasma/biologics therapy, vaccines, and iron/Kidney health, affirming CSL’s commitment to public health and life-saving care.